Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Total Current Liabilities (2016 - 2026)

Biomerica's Total Current Liabilities history spans 16 years, with the latest figure at $1.6 million for Q1 2026.

  • Quarterly results put Total Current Liabilities at $1.6 million for Q1 2026, down 5.34% from a year ago — trailing twelve months through Feb 2026 was $1.6 million (down 5.34% YoY), and the annual figure for FY2025 was $1.7 million, down 21.05%.
  • Total Current Liabilities for Q1 2026 was $1.6 million at Biomerica, down from $1.6 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $6.7 million in Q1 2022 to a low of $1.4 million in Q1 2023.
  • The 5-year median for Total Current Liabilities is $1.8 million (2022), against an average of $2.1 million.
  • The sharpest move saw Total Current Liabilities surged 395.41% in 2022, then crashed 79.17% in 2023.
  • Year by year, Total Current Liabilities stood at $1.8 million in 2022, then grew by 3.33% to $1.8 million in 2023, then grew by 2.96% to $1.9 million in 2024, then fell by 14.77% to $1.6 million in 2025, then fell by 2.38% to $1.6 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $1.6 million, $1.6 million, and $1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.